Clinical Trials Directory

Trials / Sponsors / Lyndra Inc.

Lyndra Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With
Schizophrenia, Schizoaffective Disorder
Phase 32025-04-18
CompletedStudy to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
Schizophrenia, Schizoaffective Disorder
Phase 32023-04-13
WithdrawnStudy of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
Opioid Use Disorder, Moderate
Phase 12022-02-28
CompletedA Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
Schizophrenia Schizoaffective
Phase 22020-08-13
CompletedStudy to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride i
Alzheimer Disease, Gastric Retention, Healthy
EARLY_Phase 12018-09-10
CompletedStudy to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
Gastric Retention, Healthy
EARLY_Phase 12018-06-25
TerminatedStudy Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects
Gastric Retention, Healthy
EARLY_Phase 12017-07-26